Financialsexperimental
MUNCY COLUMBIA FINANCIAL Corp (CCFN). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands
| Cash Flow | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 7,155* | 7,156 | 7,393* | 6,719* | 5,768* | 4,345 | 5,224* | 5,056* | 4,707* | 4,036 | -1,186* | 1,171* |
| Provision for credit losses | 394* | 69 | -4* | 479* | 254* | 110 | 567* | 151* | 29* | 90 | 3,114* | -168* |
| Depreciation and amortization of premises and equipment | 373* | 378 | 378* | 381* | 369* | 370 | 377* | 383* | 385* | 370 | 285* | 174* |
| Accretion of loan fair value adjustments, net | -2,497 | -2,538* | -2,631* | -2,727* | -2,789 | |||||||
| Accretion of loan fair value adjustments, net | -2,197* | -2,257 | -2,316* | -2,349* | ||||||||
| Amortization of deposit fair value adjustments, net | 97 | 140* | 228* | 336* | 481 | |||||||
| Amortization of deposit fair value adjustments, net | 41* | 43 | 51* | 56* | ||||||||
| (Gains) losses on marketable equity securities | -126* | -79 | -28* | -48* | -14* | 34 | -52* | -163* | 38* | 117 | -146* | |
| Realized losses on available-for-sale debt securities, net | -4* | -0* | 77* | -0* | -0* | 8 | ||||||
| Accretion of investment securities, net | -569* | -520 | -497* | -393* | -279* | -221 | -201* | -172* | -162* | -184 | -64* | |
| (Gains) losses on disposal of premises and equipment, net | -0* | -5 | 14* | 64* | 8* | 51 | -0* | |||||
| Gain on sale of foreclosed assets held for sale, net | 4* | -94 | -0* | -0* | ||||||||
| Deferred income taxes | 237* | 332 | 451* | 369* | 361* | 220 | 258* | 438* | 337* | 1,284 | -254* | 0* |
| Earnings on bank-owned life insurance | -257* | -232 | -226* | -235* | -233* | -231 | -236* | -236* | -113* | |||
| Loss (gain) on sale of loans | -155* | 637 | -163* | -186* | -71* | -83 | -169* | -75* | -93* | -76 | -83* | -68* |
| Proceeds from sale of mortgage loans | 6,662* | 12,298 | 6,749* | 9,848* | 2,647* | 3,675 | 7,862* | 2,156* | 3,944* | 2,257 | 3,811* | 2,852* |
| Originations of mortgage loans held for resale | -6,895* | -3,198 | -5,913* | -8,463* | -3,513* | -3,683 | -7,192* | -3,519* | -3,991* | -2,429 | -3,487* | -2,989* |
| Amortization of investment in limited partnerships | 187* | 176* | 187 | |||||||||
| Earnings on bank-owned life insurance | -227 | |||||||||||
| Amortization of intangibles | 454* | 454 | 491* | 511* | 511* | 510 | 546* | 558* | 549* | 549 | ||
| Amortization of investment in limited partnerships | 186* | 187 | 186* | 187* | 186* | 187 | 54* | |||||
| Gain on settlement of bank-owned life insurance claims | 1* | |||||||||||
| (Increase) decrease in accrued interest receivable and other assets | 204* | -630 | 269* | 98* | -41* | 707 | -10* | 237* | -228* | 513 | -427* | -333* |
| Increase in accrued interest payable and other liabilities | -1,088* | 1,995 | -1,025* | 587* | 1,070* | 1,040 | -242* | -200* | 18* | -77 | 456* | 10* |
| Other, net | 334* | 64 | 65* | 66* | 69* | 72 | -25* | 1,581* | 1,319* | -232 | -341* | 65* |
| Net cash provided by operating activities | 5,597* | 16,598 | 5,872* | 7,571* | 5,141* | 4,703 | 4,506* | 4,108* | 4,408* | 3,878 | 1,106* | 904* |
| Purchases | -15,540* | -38,639 | -15,007* | -32,357* | ||||||||
| Purchases | -0* | -0* | ||||||||||
| Proceeds from sales | 0* | 0* | 1,423* | 0* | 0* | 50,311 | 0* | |||||
| Proceeds from paydowns, calls and maturities | 31,708* | 8,032 | 8,596* | 11,827* | 25,279* | 18,771 | 19,474* | 9,732* | 4,429* | 21,688 | 17,012* | |
| Purchase of bank-owned life insurance | -24* | -20 | -0* | -3* | -24* | -20 | -0* | -0* | -24* | -20 | -0* | -0* |
| Proceeds from maturities of interest-bearing time deposits | 249* | 0* | 492* | 248 | ||||||||
| Proceeds from redemption of restricted investment in bank stocks | 2,304* | 126 | 149* | 282* | 2,040* | 2,228 | 2,448* | 1,523* | 2,183* | 4,232 | 3,523* | 1,423* |
| Purchase of restricted investment in bank stocks | -1,675* | -33 | -119* | -21* | -1,263* | -1,613 | -2,014* | -988* | -2,234* | -1,851 | -1,779* | -893* |
| Net increase in loans | -22,569* | -11,812 | -6,243* | -10,534* | -10,591* | -15,733 | -10,879* | -9,558* | -17,209* | -9,735 | -7,388* | -5,968* |
| Proceeds from sale of premises and equipment | 0* | 5 | ||||||||||
| Net increase in deposits | 46,109 | 1,820* | 24,614* | 51,791* | 62,350 | -11,375* | -17,908* | |||||
| Purchase of investment in limited partnership | -0* | -533* | ||||||||||
| Proceeds from sale of foreclosed assets held for sale | 0* | |||||||||||
| Proceeds from sale of foreclosed assets held for sale | 261* | 364 | 0* | 0* | ||||||||
| Acquisition of customer relationship intangibles | -0* | -0* | -0* | -18 | -0* | -0* | ||||||
| Acquisition of premises and equipment | -827* | -101 | -154* | -147* | -518* | -576 | -121* | -89* | -84* | -113 | -510* | -276* |
| Net cash (used for) provided by investing activities | 6,612* | -42,078 | -12,474* | -30,953* | 7,337* | 3,039 | -4,344* | 868* | -12,801* | 64,760 | 18,703* | 5,465* |
| Net increase in deposits | -20,014* | 40,773 | 15,811* | 35,771* | ||||||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 6,379 | -10,689* | 6,593* | 5,245* | -2,146 | 936* | 4,646* | |||||
| Proceeds from long-term borrowings | 0* | 0* | ||||||||||
| Net increase (decrease) in short-term borrowings | 13,642* | -1,801 | -4,438* | -1,228* | -9,561* | -40,706 | -4,637* | -16,261* | -36,627* | -126,619 | -6,622* | 17,061* |
| Repayment of long-term borrowings | -0* | -4,999* | -5,001* | -5,224 | -5,000* | -5,210* | -1* | -5,001 | -1* | -2* | ||
| Proceeds from issuance of common stock | 35* | 33 | 34* | 43* | 38* | 48 | 37* | 46* | 48* | 56 | 19* | 21* |
| Cash dividends paid | -5,181* | -1,628 | -1,591* | -1,591* | -3,357* | -1,590 | -1,554* | -1,572* | -1,573* | -1,570 | -894* | -895* |
| Net cash (used for) provided by financing activities | -52,502* | 37,377 | 9,816* | 27,996* | 4,475* | -1,363 | -10,851* | 1,617* | 13,638* | -70,784 | -18,873* | -1,723* |
| Loans held for sale transferred to loans | 0* | |||||||||||
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | -40,293* | 11,897 | 3,214* | 4,614* | ||||||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 60,437* | 48,540 | 45,326* | 40,712* | 23,759* | 17,380 | 28,069* | 21,476* | 16,231* | 18,377 | 17,441* | 12,795* |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 20,144 | 60,437 | 48,540 | 45,326 | 40,712 | 23,759 | 17,380 | 28,069 | 21,476 | 16,231 | 18,377 | 17,441 |
| Cash dividends declared but not paid | 3,537 | |||||||||||
| Interest paid | 6,810* | 6,383 | 6,777* | 6,949* | 6,940* | 6,966 | 7,714* | 8,217* | 7,817* | 8,031 | 4,284* | 3,487* |
| Income taxes paid | 950* | 625* | 125* | 50* | ||||||||
| Loans transferred to foreclosed assets held for sale | 0* | 215 | 250* | 0* | 0* | 112* | 0* | 165 | ||||
| Loans transferred to other real estate owned | 0* | |||||||||||
| Loans transferred to held for sale | 0* | 9,856 |